Last reviewed · How we verify
UK-396,082
At a glance
| Generic name | UK-396,082 |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- UK-396,082 CI brief — competitive landscape report
- UK-396,082 updates RSS · CI watch RSS
- Pfizer portfolio CI